Related Experiment Video
Updated: Apr 6, 2026

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach
Published on: July 3, 2020
A Mixed-Effects Model with Time Reparametrization for Longitudinal Univariate Manifold-Valued Data
This study introduces a new statistical model to better track Alzheimer's disease progression. It accounts for individual differences in disease onset and speed, improving predictions for patient trajectories.
Area of Science:
- Neuroscience
- Biostatistics
- Medical Imaging
Background:
- Longitudinal data analysis is crucial for understanding neurodegenerative diseases like Alzheimer's.
- Traditional mixed-effects models may not fully capture individual variations in disease progression and onset.
- Implicit reference times in models can complicate the interpretation of Alzheimer's disease trajectories.
Purpose of the Study:
- To propose a novel generative statistical model for longitudinal data in the context of Alzheimer's disease.
- To estimate an average disease progression model, incorporating subject-specific time shifts and acceleration factors.
- To provide a more accurate and individualized approach to modeling neurodegenerative disease progression.
Main Methods:
- Development of a generative statistical model within a univariate Riemannian manifold setting.
- Estimation of subject-specific time shifts to account for variability in age at disease onset.
- Estimation of subject-specific acceleration factors to account for variability in disease progression speed.
Main Results:
- The proposed model successfully analyzes longitudinal data, including neuropsychological scores and cortical thickness measurements.
- Individualized time shifts and acceleration factors allow for affine reparametrization of the average disease progression.
- The model effectively distinguishes between individuals with slow versus fast disease progression and early versus late onset.
Conclusions:
- The novel generative statistical model offers a robust framework for analyzing Alzheimer's disease progression.
- Accounting for individual time shifts and acceleration factors enhances the precision of disease progression modeling.
- This approach facilitates better identification of patient subgroups based on disease trajectory characteristics.
More Related Videos
Related Concept Videos
Multicompartment Models: Overview
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Mechanistic Models: Compartment Models in Individual and Population Analysis
Noncompartmental Analysis: Mean Residence Time
After the administration of a drug through intravenous bolus injection, the drug molecules are distributed throughout the body and remain there for varying periods. The MRT represents the average time these drug molecules stay in the...
Model Approaches for Pharmacokinetic Data: Compartment Models
Two primary types of compartment models are recognized: mammillary and catenary. The more...
Pharmacodynamic Models: Additive and Proportional Drug Effect Model

